Symbol
| NMNAT2
| contributors: mct - updated : 05-10-2016
|
HGNC name
| nicotinamide nucleotide adenylyltransferase 2
|
HGNC id
| 16789
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
constitutional
|  
|  
| --low
|  
|
may contribute to axon degeneration in a variety of neurodegenerative disorders | constitutional
|  
|  
| --low
|  
|
during cardiac hypertrophy | |
Variant & Polymorphism
|
| |
Candidate gene
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
neurology | neurodegenerative | | |
endogenous NMNAT2 represents an exciting new therapeutic target for axonal disorders | cardiovascular | cardiomyopathy | | |
modulation of NMNAT2 activity may be beneficial in cardiac hypertrophy |
| | | |